Smith Group Asset Management »

Vertex Pharmaceuticals Incorporated shares owned by Smith Group Asset Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Smith Group Asset Management from 13F filings

Historical chart of Smith Group Asset Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Smith Group Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Smith Group Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $15M 37k 406.89
2022-03-31 $5.0M 19k 260.97

More positions owned by Smith Group Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Meta Platforms Cl A (META)
Cadence Design Systems (CDNS)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Medpace Hldgs (MEDP)
CBOE Holdings (CBOE)
McKesson Corporation (MCK)
NVIDIA Corporation (NVDA)
Electronic Arts (EA)
Veeva Sys Cl A Com (VEEV)
JPMorgan Chase & Co. (JPM)
Pinterest Cl A (PINS)
Kla Corp Com New (KLAC)

View all positions for Smith Group Asset Management

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated